Citable company snapshot
Medtronic's latest SEC-sourced 2026-07-31 period shows $9.76B in revenue and $1.47B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jul 31, 2026 | $9.76B | $9.81B | -0.5% |
| Gross Profit | Apr 24, 2020 | $3.73B | $5.32B | -29.8% |
| Operating Income | Jul 31, 2026 | $1.76B | $1.87B | -5.8% |
| Net Income | Jul 31, 2026 | $1.47B | $1.24B | +18.2% |
| Operating Cash Flow | Jul 31, 2026 | $1.79B | $2.57B | -30.3% |
| Free Cash Flow (computed) | Jul 31, 2026 | $1.29B | $2.08B | -38.1% |
Source: SEC EDGAR financial statements; period Jul 31, 2026; filed Sep 3, 2026; accession 0001628280-26-060473.
MDT company research is free during early access. All you need is an account, with no card required. The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay open without one.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.